Coave Therapeutics

2 followers

‌

Coave Therapeutics develops innovative gene therapy products for rare ophthalmic diseases to preserve visual autonomy in affected patients.

Industries

Biotechnology

Headquarters

Paris, France

Employees

11-50

Links

Org chart

Rodolphe Clerval

CEO & Director

Rodolphe Clerval

Collapse

Patricia Françon

COO

Catherine Mathis

Chief Development Officer

Claudia Mitchell

Interim Chief Scientific Officer

Julien Berger

VP, Legal Affairs & Corporate Secretary

Gaelle Lefevre

Head, Discovery Sciences

Cédric Cousteix

Finance Director

Lolita Petit

Chief Scientific Officer

Marie-Anne Burlot

Preclinical Manager

Sandrine Meunier

Director Of Clinical Development At Eyedna Therapeutics A Subsidiary Of Coave Therapeutics

Teams

+12

Scientific Advisors and Researchers

15 members

Legal and Corporate Governance

12 members

Leadership Team

4 members

Similar companies

NMD Pharma

4 followers

Isotopen Technologien München

1 follower

Apogee Therapeutics

1 follower

PrognomiQ

1 follower

Altice France

6 followers

Alice & Bob

3 followers

Thermo Fisher Scientific

165 followers

Gilead Sciences

128 followers

Neuralink

60 followers

Alexion Pharmaceuticals

34 followers

Lonza

31 followers

Explore companies